We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.38%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$3.74B
AUM Growth
-$335M
Cap. Flow
-$614M
Cap. Flow %
-16.42%
Top 10 Hldgs %
21.69%
Holding
674
New
53
Increased
215
Reduced
238
Closed
121

Top Buys

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$113M
2
INTC icon
Intel
INTC
+$61.2M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$25.3M
4
CLX icon
Clorox
CLX
+$25.2M
5
TJX icon
TJX Companies
TJX
+$24.2M

Top Sells

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$107M
2
AAPL icon
Apple
AAPL
+$71.8M
3
TRV icon
Travelers Companies
TRV
+$27.6M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$27.4M
5
AXP icon
American Express
AXP
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.7%
2 Financials 10.88%
3 Technology 9.76%
4 Communication Services 9.34%
5 Consumer Staples 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GOOGL icon
1
Alphabet (Google) Class A
GOOGL
$4.3T
$118M 3.17%
+3,043,280
New +$113M
GILD icon
2
Gilead Sciences
GILD
$165B
$118M 3.15%
1,163,121
+1,331
+0.1% +$138K
INTC icon
3
Intel
INTC
$488B
$93.4M 2.5%
2,712,523
+1,811,058
+201% +$61.2M
JNJ icon
4
Johnson & Johnson
JNJ
$599B
$84.3M 2.26%
820,839
-207,632
-20% -$20.9M
CELG
5
DELISTED
Celgene Corp
CELG
$78.9M 2.11%
658,700
+9,970
+2% +$1.15M
BIIB icon
6
Biogen
BIIB
$29.5B
$74.4M 1.99%
243,019
+30,283
+14% +$8.7M
PG icon
7
Procter & Gamble
PG
$347B
$70.6M 1.89%
889,382
+274,886
+45% +$21M
PEP icon
8
PepsiCo
PEP
$185B
$69M 1.85%
690,741
+27,134
+4% +$2.71M
REGN icon
9
Regeneron Pharmaceuticals
REGN
$70.5B
$52.6M 1.41%
96,923
-10,945
-10% -$5.93M
XOM icon
10
ExxonMobil
XOM
$615B
$51.5M 1.38%
660,200
+118,604
+22% +$9.48M
NKE icon
11
Nike
NKE
$64.5B
$51.2M 1.37%
819,242
-49,746
-6% -$3.21M
MSFT icon
12
Microsoft
MSFT
$2.99T
$48.9M 1.31%
881,852
+182,195
+26% +$9.59M
SBUX icon
13
Starbucks
SBUX
$119B
$48.5M 1.3%
807,990
-11,872
-1% -$723K
PFE icon
14
Pfizer
PFE
$141B
$44.1M 1.18%
1,441,389
-58,421
-4% -$1.84M
V icon
15
Visa
V
$686B
$43.8M 1.17%
564,925
-80,354
-12% -$6.22M
MCK icon
16
McKesson
MCK
$97.3B
$39.6M 1.06%
200,664
+51,009
+34% +$9.63M
TJX icon
17
TJX Companies
TJX
$172B
$38.1M 1.02%
1,075,702
+680,628
+172% +$24.2M
T icon
18
AT&T
T
$153B
$38.1M 1.02%
1,466,607
-893
-0.1% -$22.7K
META icon
19
Meta Platforms (Facebook)
META
$1.64T
$36.6M 0.98%
350,098
+167,932
+92% +$17.3M
CLX icon
20
Clorox
CLX
$11.6B
$35.4M 0.95%
278,918
+203,205
+268% +$25.2M
VZ icon
21
Verizon
VZ
$182B
$35.1M 0.94%
759,545
-22,060
-3% -$1M
ABBV icon
22
AbbVie
ABBV
$448B
$33M 0.88%
557,682
-5,881
-1% -$339K
VRTX icon
23
Vertex Pharmaceuticals
VRTX
$122B
$30.6M 0.82%
243,162
-19,683
-7% -$2.38M
EL icon
24
Estee Lauder
EL
$30.3B
$30.3M 0.81%
343,726
+199,842
+139% +$17M
INCY icon
25
Incyte
INCY
$23.1B
$30.2M 0.81%
278,424
-18,960
-6% -$2.11M
1
2 3 4 5

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2015 Portfolio in Review

As of Q4 2015, Candriam SCA held 674 positions worth $3.74B, down 8.2% from $4.07B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Candriam SCA withdrew a net $614M in Q4 2015, closing 121 positions and reducing 238 holdings. Its most notable exit was Amgen, an estimated $107M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Financials and Technology.

Against the trend, Candriam SCA opened a new position in Alphabet (Google) Class A worth $118M.

  • Candriam SCA's largest Q4 2015 buy was Alphabet (Google) Class A: 3,043,280 shares worth $118M.
  • Candriam SCA added most to Intel in Q4 2015, an estimated $61.2M increase.
  • Candriam SCA's biggest Q4 2015 reduction was Colgate-Palmolive, cutting an estimated $21.3M.
  • Candriam SCA fully exited Amgen in Q4 2015, selling an estimated $107M.
  • Candriam SCA's ten largest holdings make up 22% of its $3.74B portfolio in Q4 2015.
  • Candriam SCA opened 53 new positions and closed 121 in Q4 2015.
  • Candriam SCA's portfolio value fell 8.2% quarter-over-quarter to $3.74B.

Based on Candriam SCA's 13F filing for Q4 2015, filed 25 Jan 2016.